10/2/2017 - home - california optometric association and oct - optowest 2018... · glaucoma...
TRANSCRIPT
10/2/2017
1
Dave Hicks, OD, FAAOOptoWest 2018
San Diego – February 11
Santa Clara – March 4
Introduction
UC Berkeley School of Optometry 2008
San Francisco VA Residency 2009
VA Staff Optometrist – teaching
Regular lecturer at AAO and other meetings
No conflicts of interest
Today’s Goals
Visual field analysis and interpretation
OCT analysis and interpretation
Touch on research about HVF and OCT
for diagnosis and progression
Case examples with OCT and HVF to
help improve glaucoma care
Case #1 - 68 year old AA male
Ocular Findings:
BCVA: 20/30-2 OD, 20/20-2 OS
Pupils: ERRL, No APD OU
Slit Lamp: 1+ NS and cortical cataracts OU
IOP: 16/17 mmHg @ 0838
Pachy: 589 μm OD, 579 μm OS
Gonio: Ciliary Body 3600, 2+ Pig. OU
Family Ocular Hx: POAG – maternal aunt
Case #1: Optic Nerves
Glaucoma or not? IOP
Advanced age
Race
Family history
Pseudoexfoliation
Pigment dispersion
Disc hemorrhages
Diabetes
Glaucoma
syndromes
Corneal thickness
Gender: NTG, POAG
Migraines: NTG
History of Trauma
History of Steroid Use
Peripapillary atrophy
Myopia
Raynaud’s phenomenon
Ocular Biomechanics
Glaucoma: Risk Factors
Most cases detected
Technology
Glaucoma Continuum
Weinreb et al. Am J Ophth. 2004;138:458-467.
.
10/2/2017
2
HVF Glaucoma Questions
How does Humphrey VF work?
What defines a glaucomatous visual field?
What are the stages of glaucoma?
How fast does glaucoma progress?
How often are visual fields necessary?
Understanding the Humphrey
Visual Field Analyzer
Testing Strategies
Evaluating Reliability
Glaucoma Hemifield Test
Visual Field Indices (MD/PSD)
Total and Pattern Deviation
Testing
Strategies
Full Threshold
FastPAC
SITA Standard
SITA Fast
Decrease test time
Maintain sensitivity and specificity
Heijl and Patella. Essential Perimetry, 3rd Ed. 2002.
Test Patterns
Central 30-2
76 test points
30 degrees each quad
Central 24-2
54 test points
30 degrees nasal
24 degrees sup/inf/temp
Points 6 degrees apart
Pick one and stick with it
Heijl and Patella. Essential Perimetry, 3rd Ed. 2002.
HVF: Reliability
Fixation Losses: <20-33%
False Positives: <15-33%
“Trigger Happy”
SITA Stnd may underestimate
Currently: >5% likely unreliable, reject >10%
False Negatives: <33%
Status of eye, not patient
84% of pts had FN in eye with more defects
Age, testing order had no effect
Bengtsson and Heijl. Invest Ophthalmol Vis Sci. 2000;41:2201-2204. Newkirk et al. Invest Ophthalmol Vis Sci. 2006; 47:4632–4637. Heijl and Patella. Essential Perimetry, 3rd Ed. 2002.
Chang, Ramulu, and Hodapp. Clinical
Decisions in Glaucoma, 2nd ed. 2016.
0% FP 28% FP
Newkirk et al. Invest Ophthalmol Vis Sci. 2006; 47: 4632-4637.
If Pattern > Total = Unreliable
10/2/2017
3
41-50 dB
Numerical and Probability Plots
Heijl and Patella. Essential Perimetry, 3rd Ed. 2002.
Probability Plots
Total Deviation Corrects for age
Highlights abnormal areas
Pattern Deviation – Most important Corrects for general depressions (cataracts)
○ 7th most sensitive point on total = pattern baseline
Highlights localized loss (glaucoma)
Brusini and Johnson. Surv Ophthalmol, 2007;52(2):156-179. Heijl and Patella. Essential Perimetry, 3rd Ed. 2002.
8% FP
5% FP
7% FP
Case #2 - Consistently Elevated FP
16% FP
15% FP
6% FP
Switched to 24-2 Case #2
0% FP
More Rarely…
Glaucoma Hemifield Test (GHT)
Compares local defects in 5 distinct zones
“Outside Normal Limits” – p<0.01
“Borderline” – p<0.03
“Generalized Depression” – under 0.5%
“Abnormally High Sensitivity” – over 0.5%
“Within Normal Limits”
High sensitivity and specificity
Good for early loss
Heijl and Patella. Essential Perimetry, 3rd Ed. 2002. Brusini and Johnson. Surv Ophthalmol, 2007;52(2):156-179.
Glaucoma Hemifield Test (GHT)
Heijl and Patella. Essential Perimetry, 3rd Ed. 2002.
10/2/2017
4
VF Indices (MD and PSD)
Mean Deviation (MD) Weighted average of dB values from total
deviation plot
Shows average amount of change from age matched normal subjects for entire VF
Can be affected by cataract
Pattern Standard Deviation (PSD) Low PSD = smooth hill of vision
High PSD = pt variability or irregular VF
Bengtsson et al. Arch Ophthalmol, 2009;127(12):1610-1615. Heijl and Patella. Essential Perimetry, 3rd Ed. 2002.
Variations in MD and PSD
Normal MD, higher PSD
= local defect
Low MD, normal PSD =
diffuse loss
MD -5.93dB
PSD 1.57dB
MD -0.06dB
PSD 5.41dB
Normal
Lower MD =
diffuse loss
Higher PSD =
irregularity
Using HVF for Glaucoma Basic Glaucoma VF Rules
1. Asymmetric across horizontal midline (early/mod)
2. Midperipheral (early/mod)
3. Clustered points
4. Reproducible 2x or more
5. Not explained by other diseases
6. Representative of pt’s functional status (FPs, FLs)
Foster et al. Br J Ophthalmol, 2002;86:238-242.
Common Glaucoma VF Patterns
Arcuate scotoma
Bjerrum/Seidel
Nasal step
Paracentral
Temporal wedge
Overall depression
Transient changes
Hiejl. Surv Ophthalmol, 1989;33:403-404.
Heijl and Patella. Essential Perimetry, 2002.
Paracentral Temporal Wedge
Partial Arcuate – Mild and Severe
https://vrcc.wustl.edu/vfrc/vfrc.html
Early Central Glaucoma Inferior Nasal Arcuate/Step
Heijl and Patella. Essential Perimetry, 3rd Ed. 2002.
Superior Arcuate Scotoma Advanced Double Arcuate Scotoma
Heijl and Patella. Essential Perimetry, 3rd Ed. 2002.
10/2/2017
5
Watch Out For…
Chang, Ramulu, and Hodapp. Clinical Decisions in Glaucoma, 2nd ed. 2016.
Glaucoma VF Definition (HAP)
GHT “Outside Normal” on at least 2 VFs
OR
Cluster of 3+ contiguous non-edge points
p< 5% on PD and 1+ points p< 1%
OR
Corrected PSD <5% on 2 VFs
(2 consecutive VFs for last 2 definitions)
Hodapp, Parrish, Anderson. Clinical Decisions in Glaucoma. 1993.
New Glaucoma VF Definition (HAP2)
Any of the following must be reproducible on two consecutive 24-2 VFs:
GHT “Outside Normal Limits”
A cluster of 3+ points in a location typical for glaucoma, all of which are depressed at a p<5% level on the pattern deviation plot and one of which is depressed at a p<1% level
PSD that occurs in <5% of normal VFs
Chang, Ramulu, and Hodapp. Clinical Decisions in Glaucoma, 2nd ed. 2016.
New Glaucoma VF Definition (HAP2)
Chang, Ramulu, and Hodapp. Clinical Decisions in Glaucoma, 2nd ed. 2016.
3 points <5%
1 points <1%
Case #3 - 62 year old Asian male
Ocular Findings:
BCVA: 20/25 OD and 20/30 OS
Pupils: ERRL, No APD OU
Slit Lamp: 1-2+ NS and cortical OU
IOP: 12/12 mmHg @ 0835
Fundus: Unremarkable OU
Family Ocular Hx: Unremarkable
Medical Hx: DM, hyperlipidemia, sleep apnea
Case #3 – Optic NervesCase #3
Baseline HVF
10/2/2017
6
Repeat HVF – 1 month later
a) 2 consecutive VFs with GHT
Outside Normal Limits
b) Cluster 3+ points in typical location
p< 5% on PD with 1+ points p< 1%
3rd HVF – 6 months laterStaging Glaucoma
Has evolved in last 25 years
Now part of ICD-10
Baseline = 2 HVFs
Hodapp, Parrish, Anderson. Clinical Decisions in Glaucoma. 1993.
Chang, Ramulu, and Hodapp. Clinical Decisions in Glaucoma, 2nd ed. 2016.
Staging: ICD-10
Mild or early: pre-perimetric (normal VF)
Moderate: ONH abnormalities c/w
glaucoma and VF abnormalities in 1
hemifield, but not within 50 of fixation
Chang, Ramulu, and Hodapp. Clinical Decisions in Glaucoma, 2nd ed. 2016.
Staging: ICD-10
Severe: ONH abnormalities c/w
glaucoma and VF abnormalities in both
hemifields and/or loss within 50 of
fixation in 1 hemifield
Indeterminate: ONH abnormalities c/w
glaucoma without VF data
Chang, Ramulu, and Hodapp. Clinical Decisions in Glaucoma, 2nd ed. 2016.
HAP2 Staging Criteria
Early defect – neither extensive
nor near fixation
Must meet all 3 criteria:
1. MD > -6 dB
2. No point in central 50 can be <15dB
3. Less than 25% (1-12 points) are <5% level and <10% (1-4 points) are <1% level on pattern deviation (PD)
Chang, Ramulu, and Hodapp. Clinical Decisions in Glaucoma, 2nd ed. 2016.
Mild (need all 3)
MD: >-6dB
No central pts
<15db
PD: 1-12 pts <5%
and 1-4 pts <1%
Moderate (need 1)
MD: -6 to -12dB
No central pts 0db
PD: 13-26 pts <5%
PD: 5-13 pts <1%
MD -1.04
9 points <5%
2 points <1%
O central points <15db
Early or Mild Defect HAP2 Staging Criteria
Severe defect – Only 1 necessary:
1. MD < -12 dB
2. More than 50% (27+ points) are <5% level and
more than 25% (14+ points) are <1% on PD
3. Any point in central 50 is 0 dB
4. Both hemifields have points <15dB within
central 50
Chang, Ramulu, and Hodapp. Clinical Decisions in Glaucoma, 2nd ed. 2016.
MD: -19.69dB
35 points <5%
31 points <1%
O central points <15db
Severe Defect Moderate (need 1)
MD: -6 to -12dB
No central pts 0db
PD: 13-26 pts <5%
PD: 5-13 pts <1%
Severe (need 1)
MD: < -12dB
Any central pts 0db
PD: 27+ pts <5%
PD: 14+ pts <1%
Both hemifields
central pts <15dB
10/2/2017
7
HAP2 Staging Criteria
Moderate defect – any VF defect that is
neither early nor severe
At least one of the following is present:
1. MD is between -6 dB and -12 dB
2. 25-50% (13-26 points) are <5% level and
10-25% (5-13 points) are <1% level on PD
3. No point in central 50 is 0 dB
4. Only 1 hemifield has a point of <15dB within
central 50
Chang, Ramulu, and Hodapp. Clinical Decisions in Glaucoma, 2nd ed. 2016.
MD: -5.07dB
17 points <5%
10 points <1%
O central points <15db
Moderate Defect Mild (need all 3)
MD: >-6dB
No central pts
<15db
PD: 1-12 pts <5%
and 1-4 pts <1%
Moderate (need 1)
MD: -6 to -12dB
No central pts 0db
PD: 13-26 pts <5%
PD: 5-13 pts <1%
VF Progression
NO WIDELY ACCEPTED STANDARD!
Most authors agree:
Deepening or expansion of an existing scotoma
New defect in a previously normal area
Risk factor analysis
Spry and Johnson. Surv Ophthalmol, 2002;47(2):158-173.
Giangiacomo et al. Curr Op in Ophthalmol, 2006;17:153-162.
Drance et al. Am J Ophthalmol, 2001;131:699-708.
Sample. Surv Ophthalmol, 2001;45(S3):S319-S324.
Major Challenges
Every clinical trial has different criteria
Large differences in testing analyses
Methods for determination only agree about 50-
60% of the time
Suspected changes have to be confirmed
Variability is huge amongst populations
Rates of VF change are not constant
No consensus among major investigators
Brusini and Johnson. Surv Ophthalmol, 2007;52(2):156-179.
CNTGS 20% progress even with 30% in IOP
50% have no VF progression without tx
EMGT Untreated controls had a median time to
progression of 4 years
60% progress in 6 yearsOliver et al. Am J Ophthalmol, 2002;133(6):764-772.
Clinical judgment
Defect classification systems
HAP, HAP2, AGIS, CIGTS
Event analysis
Greater change than expected (GPA)
Trend analysis
Rate over time (MD, VFI, etc)
All have pros and cons
Be consistent and evidence-
based in your decisions
Spry and Johnson. Surv Ophthalmol, 2002;47(2):158-173.
Determining ProgressionVF Progression: HAP2
Requires at least 2 consecutive VFs
New defects in previously normal area:
1 point >10dB
Within central 100 – 2+ points >5dB
Outside central 100 – 3+ points >5dB
Chang, Ramulu, and Hodapp. Clinical Decisions in Glaucoma, 2nd ed. 2016.
VF Progression: HAP2
Within preexisting defects:
1 point >15dB
Within central 100 – any point >10dB
Outside central 100 – 3+ points >10dB on 2 consecutive VFs or >5dB on 3 consecutive
Either of these on GPA:
Slope of p<1% on VFI or “Likely Progression” on GPA
Chang, Ramulu, and Hodapp. Clinical Decisions in Glaucoma, 2nd ed. 2016.
10/2/2017
8
Classic
Progression
Heijl, Patella, Bengtsson. Effective Perimetry, 4th Ed. 2012.
Chang, Ramulu, and Hodapp.
Clinical Decisions in
Glaucoma, 2nd ed. 2016.
Long Term Fluctuations (LTF)
Giangiacomo et al. Curr Opinion in Ophthalmol, 2006;17:153-162.
2006
2013
2013
2015
Progression - OHTS
At 5 years, 90.5% of untreated patients showed no ONH or VF progression 9.5% in the observation group progressed
4.4% in the treatment group progressed
85.9% of eyes with initial VF defects had normal repeat VF
Change in MD of -0.08 dB/yr
Keltner et al. Arch Ophthalmol, 2005;123:1201-1206.Kass MA, et al. Arch Ophthalmol, 2002; 120:701-713.
Demirel S, et al. IOVS, 2002; 53:224-227.
Keltner et al. Arch Ophthalmol, 2000;118:1187-1194.
Confirming Progression
AGIS – 12,746 VFs over 10-13 years
Sustained decreased VFs (SDVF)
Can temporarily recover
55% with SDVF on 2 visits, 40% on 3 visits
showed recovery
Repeat VF at least once!
AGIS Investigators. Ophthalmology, 2004;111:2109-2116.
Visual Field Index (VFI)
Summary index on 24-2 and 30-2 tests
Calculated by all test points in pattern dev’n
Normal points (p>5%) = 100%, 0 dB points = 0%
Eccentricity-weighted mean of scores
Gives visual function as % of normal age VF
Resistant to cataract
Used to judge rate of progression
Bengtsson et al. Arch Ophthalmol, 2009;127(12):1610-1615.
10/2/2017
9
Guided Progression Analysis (GPA)
Calculates rate of progression from VFI
1-2 page summary report
Baseline exams at top
VFI trends in middle
Current exam at bottom
Uses oldest 2 exams as baseline Can and should be changed*
Zeiss. HFA II-i Manual. 2008.Nouri-Mahdavi et al. Graefes Arch Ophthalmol, 2011;249:1593-1616.
How many VFs are needed?
OHTS: 3 consecutive, abnormal, reliable
Originally 2 VFs, but 66% then were WNL
HAP and HAP2: 2 reliable for baseline
WGA: 2 reliable baseline in 6 months, then 2
more within 18 months
CIGTS: 2+ for confirmation
CNTGS: 2-3 in 1st month & 2-3 at 3 months
HVF algorithms: 2 to 6 for analysis
Giangiacomo et al. Curr Opinion in Ophthalmol, 2006;17:153-162.
Hodapp,Parrish, Anderson. Clinical Decisions in Glaucoma. 1993.
Keltner et al. Arch Ophthalmol, 2005;123:1201-1206.
Jampel et al. Ophthalmol, 2011;118:986-1002.
10/2/2017
10
No single definition of progression exists Pick an evidence-based approach that works for
your patient population
Repeat VF when a change is suspected Set new baselines as needed
Use software to your advantage VFI and GPA are fast and easy to use
Rates of progression vary Determine an acceptable rate for each patient
VF Progression: Quick Review
Today’s Goals
Discuss analysis of optic nerve OCTs
Review strengths and weaknesses of OCT for glaucoma management
Review recent research about OCT for diagnosis and judging progression
Provide tips for improved use of OCT in clinical practice
Available OCTs
Zeiss Cirrus
Heidelberg Spectralis
Nidex 3000
Canon Copernicus
RTVue
Opko/OTI Spectral OCT/SLO
Topcon 3D-OCT
Zeiss Stratus (Time Domain)
Spectral vs. Time Domain
Similarities/differences in databases Color codes do not agree well
Progression between instruments?
SD-OCT advantages: Higher resolution, decreased scanning time
Better repeatability of RNFL measurements
More data – peripapillary scans with RNFL thickness maps, macular GC analysis, etc
Better for diagnosis and progression
Leung et al. Ophthalmol, 2010;117:1684–1691. Jeoung, Park. IOVS, 2010;51:938-945.
Kim et al. IOVS, 2012;53:3193-3200.Savini et al. Curr Opin Ophthalmol, 2011;22:115-123.
10/2/2017
11
http://www.optovue.com/pdf/RT
Vue-FD-OCT-Brochure.pdf
Influential Factors?
Normative
databases
Media
ONH size
ONH distance to
foveola
PPA
Retina
Axial length
Interocular
symmetry
Refractive error
Age
Sex
Race
Stratus Database
328 subjects
48% male, 52% female
Mean age 47.4 +/- 15.8 yrs, range 18-85
Rx: -11.75 to +6.75, mean -0.54
63% Caucasian, 24% Hispanic,
8% African American, 11% Asian
No eye surgery except cataract (9 pts), no ocular disease, IOP <22, normal and reliable VF, normal ONH, BCVA >20/32
Budenz et al. Ophthalmol, 2007;114:1046-1052.
Cirrus Database
284 subjects
47% male, 53% female
Age range 19-84
Only 3 pts >80 and 28 pts between 70-79
Rx: -12 to +8
43% Caucasian, 18% African American, 12% Hispanic, 1% Indian, 6% mixed
All normal subjects
Cirrus HD-OCT 510(k) Summary. FDA. Jan 2012.Chong, Lee. Curr Op Ophthal, 2012; 23:79-88.
Spectralis Database
201 subjects, all Caucasian
55% male, 45% female
Mean age 48.2 +/- 14.5 yrs, Range 18-78
Only 1 pt <20 and only 13 pts >70
Rx: -7 to +5
No glaucoma, normal IOP, normal VF,
normal optic nerve, etc
Spectralis HRT+OCT 510(k) Summary. FDA. Oct 2010
RTVue Database
861 subjects, various ethnicities
Largest available database
Mean age 50 +/- 15.5 yrs, Range 19-82
Rx: -8 to +8 sphere, -2 to +2 cylinder
No glaucoma, normal IOP, normal VF,
normal optic nerve, etc
Average RNFL Thickness
Stratus: 99-100um in Caucasian/Japanese
132.7um in Hispanics
Spectralis: 89-97.3um +/- 9.6 to 15.87um
African American 99.2um, Caucasian 96um
Cirrus: 84-94um +/- 13.68um
Superior quad up to 122um, inferior quad up to 127um
RTVue: 107.9 +/- 10um
African American 107um, Caucasian 102um
Topcon: 102um
Alasil et al. J Glaucoma, 2013 Sep;22(7):532-41.Budenz et al. Ophthalmol, 2007;114:1046-1052.
84-108um
Red-Green Disease
Color code determined by the database
of the instrument
Based on probability of that population only
15-36% of OCTs for glaucoma may
contain artifacts that influence red-
green analysis
Asrani, et al. JAMA Ophthalmol, 2014; 132(4):396-402.
10/2/2017
12
Media and Eye Mvmts
Aref AA, Budenz DL. Ophthal Surg Lasers Imaging, 2010;41:S15-S27.
ONH Size/Disc Area
Larger ONH means OCT scan is closer to ONH RNFL decreases as measurement diameter increases
Overestimates RNFL in some studies but not others
Thicker RNFL measurements in larger ONH 3.3um per 1mm2 (Budenz 2007)
RNFL thickness correlates with disc area (Hirasawa 2010, Japanese)
No association between ONH size and RNFL thickness (AIGS 2012)
Budenz et al. Ophthalmol, 2007;114:1046-1052.
Hirasawa et al. Arch Ophthalmol, 2010;128(11):1420-1426. Huang et al for AIGS. IOVS, 2012;53:4990-4997.
Cirrus
Small: <1.66mm2
Medium: 1.66-1.97mm2
Large: >1.97mm2
Only 5% of eyes in normal database were
<1.33mm2 or >2.5mm2 with Cirrus
Stratus: 2.26mm2 mean disc area
RTVue: Range 1.86-2.1mm2
Disc Area Measurements
Budenz et al. Ophthalmol, 2007;114:1046-1052.Knight et al. Arch Ophthalmol, 2012 Mar;130(3):312-8.
ERM
10/2/2017
13
Date of download: 7/11/2014Copyright © 2014 American Medical
Association. All rights reserved.
From: Artifacts in Spectral-Domain Optical Coherence Tomography Measurements in Glaucoma
JAMA Ophthalmol. 2014;132(4):396-402. doi:10.1001/jamaophthalmol.2013.7974 ERM
Liu et al. AJO, 2015;159:565-576.
PPA
Present in 15% of normals but 62-84%
of glaucoma patients
Stratus overestimates disc size in
glaucoma patients and controls
Cirrus performs well compared to
clinical disc evaluation
Kim C, Radcliffe N. APJ Ophthal, Nov/Dec 2012;1(6):364-373.Kim et al. IOVS, 2012;53:3193-3200.
Axial Length
Variable relationship in the literature No correlation of axial length and RNFL (Hirasawa 2010)
RNFL thickness with axial length (Ueda 2015)
If temporal quadrant is thick, superior and
inferior thinning could be due to refractive error (Alasil 2012, Ueda 2015)
Be cautious of thinning in myopic
Caucasians
Hirasawa et al. Arch Ophthalmol, 2010;128(11):1420-1426.Vernon et al. Br J Ophthalmol, 2008;92:1076-1080.
Alasil et al. J Glaucoma, 2013 Sep;22(7):532-41.Leung et al. IOVS, 2012 Oct 17;53(11):7194-7200.
Budenz et al. Ophthalmol, 2007;114:1046-1052.Ueda et al. J Glaucoma, 2015 Jan 12. Epub.
Hong, Anh, Kand. IOVS, July 2010;51(7):3515-3523.
Leung, et al. IOVS, 2012 Oct 17;53(11):7194-7200.
34 y/o
10/2/2017
14
34 y/oOther Factors
Rx:
RNFL thinner by 1.2um/diopter of myopia
Race:
RNFL decreases from Hispanics>Asians> African Americans>Caucasians
Differences in ONH area, ave C/D, vert C/D, cup volume also
FOHx:
Patients with FOHx of glaucoma have thinner RNFL and GCC than normals
Knight et al. Arch Ophthalmol, 2012 Mar;130(3):312-8.Alasil et al. J Glaucoma, 2013 Sep;22(7):532-41.
Rolle et al. BJO, 2014; in press
Utility of OCT in glaucoma
RNFL loss precedes VF loss by 6 years in 60% of eyes
In OHTS, HRT showed glaucomatous change 8 years before VF defects
17% RNFL loss before VF detection
Progressive optic disc changes may not correspond to RNFL thinning in the same eyes with glaucoma progression
Wollstein et al. BJO, 2012;96:47-52. Sommer, Katz, Quigley. Arch Ophthalmol, 1991;111:485-490.
Glaucoma Detection
Both TD and SD have high sensitivity and specificity for glaucoma when >1 clock hour is <5% level (yellow)
Both TD and SD may be inadequate in detecting preperimetric RNFL defects
Worse when defects <10 degrees
Cirrus can discriminate mild glaucoma from normal using ONH parameters Vertical rim thickness (VRT), Rim area, Vertical C/D
Leung et al. Ophthalmol, 2010;117:1684–1691. Jeoung, Park. IOVS, 2010;51:938-945.
Mwanza et al. Ophthalmol, 2011;118:241-248.
Glaucoma Detection
RNFL parameters:
Average/global RNFL thickness*
RNFL thickness at infero-temporal*
○ (3,4,9 o’clock are most variable)
RNFL thickness inferior quadrant
Additional useful information:
Cirrus – RNFL deviation-from-normal map
Stratus – TSNIT
Asymmetry
Jeoung, Park. IOVS, 2010;51:938-945.
Mwanza et al. Ophthalmol, 2011;118:241-248.Lisboa et al. Ophthalmol, 2012;119 (11):2261-2269.
Abnormal RNFL Thickness
Average RNFL <5th percentile
Yellow or red
Any quadrant <5th percentile
Yellow or red
Any clock hour <1st percentile
Red
Chang, Ramulu, and Hodapp. Clinical Decisions in Glaucoma, 2nd ed. 2016.
Abnormal RNFL Contour (TSNIT)
Any focal thinning superior or inferior
Especially if yellow or red
Any significant asymmetry between
contour of OD and OS, especially
superior or inferior
Chang, Ramulu, and Hodapp. Clinical Decisions in Glaucoma, 2nd ed. 2016.
Case #4 - 45 year old Caucasian male
Ocular Findings:
BCVA: 20/20 OD, 20/25+2 OS
Pupils: ERRL, no APD
Slit Lamp: trace NS, no PXF OU
IOP: 22/23 mmHg @ 0841
C/D: 0.35 OD and OS
Fundus: normal OU
10/2/2017
15
2/1/13 5/13/13 6/18/132/1/13 8/20/13
4/21/14 1/5/15Interocular symmetry
Increasing age is not associated with
increased RNFL asymmetry
Spectralis: 6.6x greater asymmetry in
glaucoma vs. normal
Difference of 6um for RNFL global average had
high sensitivity and specificity to detect POAG
Macular asymmetry has also proven
sensitive and specific (Sullivan-Mee)
Sullivan-Mee et al. Am J Ophthalmol, 2013; 156:567-577.Field et al. J Glaucoma, 2014; in press.
Mwanza et al.
Ophthalmol, 2011;118:241-248.
>9 um difference may be indicative
of early glaucoma OCT is a validated technology for
glaucoma detection
Variations exists between instruments
Average RNFL thickness = ~84-108um
Use caution when interpreting OCTs
Normal eyes can appear glaucomatous
Detection: Quick Review
10/2/2017
16
Progression: Considerations
Variable nature of glaucoma
Event-based vs. trend-based analyses
Changing technology – longitudinal f/u
Instrument variability
No consensus on limit of RNFL thinning that equals progression; no reference standard
Eyes without VF loss?
Mwanza et al. IOVS, 2010;51:5724-5730.Grewal et al. Curr Opin Ophthalmol, 2013;24:150-161.
Reliability and Reproducibility
Inter-visit repeatability is good for
most SD-OCT
Signal strength: 7 or greater desired
Dilation: may not effect repeatability
Variability vs. progression?
Progressive RNFL thinning occurs with increased glaucoma severity
Abnormal (thinner) RNFL may show less inter-visit variability than normal (thicker) RNFL
Severe glaucoma can potentially have more functional loss with smaller RNFL changes
Assumptions To Remember
Chang, Ramulu, and Hodapp. Clinical Decisions in Glaucoma, 2nd ed. 2016.
Variability vs. Progression
Stratus
Test-retest variability of ~4-10um per quadrant
Be suspicious of changes over 10um
Cirrus
Ave RNFL thinning of >4-6um between visits is suspicious
Spectralis
Clinically appears to have very low fluctuation
Global 5-14um intra- and inter-visit variation
Roh et al. Ophthalmol, 2013;120(5):969-977.Mwanza et al. IOVS, 2010;51:5724-5730.
Toscano et al. Arq Bras Oftalmol, 2012;75(5):320-3.Hong et al. Korean J Ophthalmol, 2012;26(1):32-38.
Leung et al. IOVS, 2008;49:4886-4892.
Suspected Progression
Variability: Average RNFL: ~5um
By quadrant: ~8um
By clock hour: ~10-12um
Thinning of >10um (or maybe 20um) are more concerning, especially I/T and S/T
Suspicious OCTs should be repeated
Ghasia et al. J Glaucoma, 2013; May 29 [E-pub].Mwanza et al. IOVS, 2010;51:5724-5730.
8/201112/2012
Case #5 - 68 year old male1/9/15 Case #5 7/24/15
10/2/2017
17
Case #5 4/12/17
Repeat OCTs before making treatment
decisions
41-56% of abnormal scans were not
duplicated on f/u exams
Consider abnormal if 2 of 3 RNFL or
GCIPL scans are borderline or ONL
Some suggest up to 5 tests (linear regression)
Recommendations
Iverson, et al. Br J Ophthalmol, 2014;98:920-925.
Serial, good quality OCTs can help detect
progression
For patients who can NOT do VFs:
Early glaucoma: average RNFL 8um
Mod/severe glaucoma: ave RNFL 4um
HAP2 Recommendations
Chang, Ramulu, and Hodapp. Clinical Decisions in Glaucoma, 2nd ed. 2016.
For patients who can do reliable VFs
No VF defect: average RNFL 10um
New VF defect or disc heme: RNFL 5um
If severe glaucoma with RNFL <60um, a
stable OCT does NOT rule out progression
HAP2 Recommendations
Chang, Ramulu, and Hodapp. Clinical Decisions in Glaucoma, 2nd ed. 2016.
Types of RNFL Change
Inferotemporal is most common in glaucoma
Widening of RNFL defect (85.7%)
Development of new RNFL defect (17.9%)
Other optic neuropathies can cause RNFL
thinning, but patterns are different
Age related thinning is most common
superior and inferior
Alasil et al. J Glaucoma, 2013 Sep;22(7):532-41.Leung et al. Ophthalmol, 2012;119(9):1858-1866.
Shin et al. Ophthalmology 2014;121:1990-1997.
Age-Related RNFL Loss
Average rate: -0.10 to -0.52um/yr or
1.5-2um/decade
Greater baseline thickness = faster
rate of change
No significant change in nasal and
temporal quadrants with age
Rate in glaucoma is faster
> -2.54 um/yr is significant
Leung et al. Ophthalmol, 2012;119:731-737.Budenz et al. Ophthalmol, 2007;114:1046-1052.
Alasil et al. J Glaucoma, 2013 Sep;22(7):532-41.Ueda et al. J Glaucoma, 2015 Jan 12. Epub.
84 y/oGPA
Cirrus: GPA available for OCT or HVF or combined analysis for both
Pros: OCT GPA on Cirrus is useful to judge
progression when VF defect is mild
Cons: Agreement between OCT GPA and disc
photos or VF analysis can be poor
Subject to artifacts in scans
Leung et al. IOVS, 2010;51:217-222. Tenkumo et al. Jpn J Ophthalmol, 2013 Jun 25. [Epub]
Na et al. Curr Eye Res, 2013 Mar;38(3):386-95.
4/2011 6/2013
10/2/2017
18
Case #4
1/5/15
Macular OCT
Useful in advanced
glaucoma
Papillomacular bundle
preservation
Early glaucoma
detection
High discriminating
power
High reproducibility
Sung et al. Ophthalmol, 2012;119: 308-313. Grewal et al. Curr Opin Ophthalmol, 2013;24:150-161.
Nakatani et al. J Glaucoma, 2011;20:252-259.
Hood et al. IOVS, 2014: 55: 632-649.Jeong et al. J Glaucoma, 2015: in press
Hood et al. Prog Retin Eye Res,
2013: Jan; 32C:1-21.
Ganglion Cell Analysis (GCA)
Macular RGC complex is 1-7 cells thick: RNFL, GCL and IPL Contains 50% of retinal RGCs
Average RGC count is lower in eyes with early VF defects: 652K vs 911K RGC loss of 7877 per year
RGC counts were better than average RNFL thickness for detecting glaucoma with early/minimal VF loss
Medeiros et al. Ophthalmol, 2013;120:736-744.Medeiros et al. Am J Ophthalmol, 2012;154:814-824.
Shin et al. Ophthalmol, 2013; in press.
10/2/2017
19
Ganglion Cell Analysis
Macular RGC counts can be affected by drusenand AMD
GCIPL thinning with thinner RNFL, older age, longer axial length, and males
GCIPL and total macular thickness (TMT) have similar sensitivity in detecting glaucoma progression Average RNFL was better in diagnosis
Minimum GCIPL is best parameter for early perimetric glaucoma detection and is similar to best RNFL or ONH parameters (Mwanza, Jeoung)
Na et al. IOVS, 2012;53:3817-3826. Mwanza et al. Ophthalmol, 2014;121:849-854.
Mwanza et al. IOVS, 2011;52:7872-7879.Jeoung JW et al. IOVS, 2013;54:4422-9.
http://www.heidelbergengineering.com/us/wp-content/uploads/2134_Info-Sheet_Posterior-Pole_Final-Low-Res.pdf
Glaucoma is likely when:
Intereye macular thickness asymmetry >5 um Intraeye macular thickness asymmetry >9 um Intereye RNFL thickness asymmetry >9 um Global RNFL thickness <78 um
*Spectralis
Sullivan-Mee et al. Am J Ophthalmol, 2013; 156:567-577. Hwang YH, Anh SI, Ko SJ. Clin Exp Ophth, 2015; in press.
Ganglion cell asymmetry shows good
diagnostic ability in early glaucoma
Image courtesy of John Hammer
at Carl Zeiss
OCT: Conclusions
OCT is great technology but it isn’t perfect
Correlate HVF and OCT findings
Evaluate scan data and not just colors
Remember artifacts, instrument capabilities, etc
No set standard for OCT progression
Research studies vs. clinical care
Repeat OCTs and correlate with other
findings before making treatment decisions